Listed

PepGen Inc.

PEPGNasdaqCIK 1835597HealthcareFiscal year ends Dec 31

Reports and events: 99 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

PepGen Inc., Reports and events
FiledFormWhat it isAccession number
2024-03-2908:15 ET10-K/AAnnual report, amendedPeriod 2023-12-310000950170-24-038417
2024-03-1516:01 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-24-069110
2024-03-1307:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-030505
2024-03-1119:56 ETSC 13D/AOwnership report, active investor, amended0001104659-24-033131
2024-03-0616:23 ET10-KAnnual reportPeriod 2023-12-310000950170-24-027178
2024-03-0616:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-027111
2024-03-0407:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-024350
2024-02-2008:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-016804
2024-02-1316:16 ETSC 13D/AOwnership report, active investor, amended0001104659-24-019896
2024-02-0707:36 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-025921
2024-01-1708:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-004824
2024-01-0807:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-002679
2023-12-1808:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-070944
2023-11-1508:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-064008
2023-11-0808:30 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-060702
2023-11-0808:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-060693
2023-10-1207:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-052999
2023-09-0616:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-046722
2023-09-0608:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-046572
2023-08-0808:27 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-205630
2023-08-0808:17 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-039392
2023-08-0808:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-039391
2023-06-2216:05 ET8-K5.07 Shareholder vote results0000950170-23-029394
2023-06-1316:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-027696
2023-05-3016:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-024842
2023-05-1807:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-022875
2023-05-1107:11 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-020829
2023-05-1107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-020826
2023-04-2816:00 ETDEF 14AProxy statementPeriod 2023-06-220000950170-23-015751
2023-03-2716:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-010040
2023-03-2316:16 ET10-KAnnual reportPeriod 2022-12-310000950170-23-009500
2023-03-2316:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-009480
2023-03-2208:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-009049
2022-12-0708:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-026120
2022-11-1409:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-024767
2022-11-1008:16 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-024186
2022-11-1008:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-024184
2022-09-2806:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-018928
2022-09-2208:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-22-018744
2022-08-1208:16 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-017013
2022-08-1208:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-017010
2022-07-2208:32 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-22-012897
2022-06-2316:49 ETSC 13D/AOwnership report, active investor, amended0001104659-22-073935
2022-06-1608:34 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-011719
2022-06-1608:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-011718
2022-05-2016:30 ETSC 13DOwnership report, active investor0001104659-22-063397
2022-05-0417:08 ETS-1/ARegistration statement, amended0001193125-22-140581
2022-05-0206:24 ETS-1/ARegistration statement, amended0001193125-22-135245
2022-04-1516:55 ETS-1Registration statement0001193125-22-106884

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.